Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Glaukos Corp
(NY:
GKOS
)
96.86
+1.73 (+1.82%)
Streaming Delayed Price
Updated: 12:13 PM EDT, Apr 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
235,528
Open
95.00
Bid (Size)
96.69 (2)
Ask (Size)
96.87 (1)
Prev. Close
95.13
Today's Range
95.00 - 98.70
52wk Range
45.38 - 102.33
Shares Outstanding
49,470,423
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Glaukos Announces the Release of its 2023 Sustainability Report
April 16, 2024
From
Glaukos Corporation
Via
Business Wire
Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1
April 10, 2024
From
Glaukos Corporation
Via
Business Wire
Performance
YTD
+25.66%
+25.66%
1 Month
+10.55%
+10.55%
3 Month
+6.66%
+6.66%
6 Month
+45.41%
+45.41%
1 Year
+95.32%
+95.32%
More News
Read More
Analyst Ratings For Glaukos
April 08, 2024
Via
Benzinga
Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On Wednesday
April 03, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
5 Analysts Have This To Say About Glaukos
March 22, 2024
Via
Benzinga
Glaukos: Q4 Earnings Insights
February 21, 2024
Via
Benzinga
Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant)
April 03, 2024
From
Glaukos Corporation
Via
Business Wire
Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
April 01, 2024
From
Glaukos Corporation
Via
Business Wire
Analog Devices To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
February 22, 2024
Via
Benzinga
Earnings Scheduled For February 21, 2024
February 21, 2024
Via
Benzinga
Analyst Ratings For Glaukos
February 16, 2024
Via
Benzinga
Unveiling 7 Analyst Insights On Glaukos
December 21, 2023
Via
Benzinga
Analyst Ratings for Glaukos
November 28, 2023
Via
Benzinga
Glaukos Announces Fourth Quarter and Full Year 2023 Financial Results
February 21, 2024
From
Glaukos Corporation
Via
Business Wire
Glaukos to Release Fourth Quarter and Full Year 2023 Financial Results after Market Close on February 21
January 31, 2024
From
Glaukos Corporation
Via
Business Wire
Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2023 Net Sales and Reaffirms 2024 Revenue Guidance
January 09, 2024
From
Glaukos Corporation
Via
Business Wire
Glaukos' Newly Approved Glaucoma Treatment Is The 'Biggest Driver To Watch': Analyst
December 21, 2023
Via
Benzinga
4 Analysts Have This to Say About Glaukos
November 08, 2023
Via
Benzinga
Amazon.com To Rally Over 38%? Here Are 10 Top Analyst Forecasts For Thursday
December 21, 2023
Via
Benzinga
Glaukos Announces Participation in the J.P. Morgan Healthcare Conference
December 20, 2023
From
Glaukos Corporation
Via
Business Wire
iDoseTR Approval Sets Stage for Glaukos' Game-Changing Product, Surpassing Market Expectations, Says Analyst
December 15, 2023
Via
Benzinga
Exposures
Product Safety
Dow Extends Rally As Treasury Yields Tank
December 14, 2023
Via
Talk Markets
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
FDA Approves Glaukos' Eye Implant To Treat Eye Pressure In Glaucoma Patients
December 14, 2023
Via
Benzinga
Exposures
Product Safety
Glaukos Announces FDA Approval of iDose® TR (travoprost intracameral implant)
December 14, 2023
From
Glaukos Corporation
Via
Business Wire
Glaukos Announces Participation in Stifel Healthcare Conference
November 07, 2023
From
Glaukos Corporation
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.